18 hrs ago | WJLA
ABC 7 News - Redskins Super Bowl MVP Visits Walter Reed
He hoped to "bring a little light and a little bit of solace for these families." But it was a little girl, Emma, that caught his eye -- and ours.
ASCO Releases Annual Progress Report On Top Cancer Research Advances
The American Society of Clinical Oncology released its report, Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention and Screening, an independent assessment of the most significant clinical cancer research studies of the past year, including 15 major advances.
1 in 7 men will get prostate cancer but 95% will survive
It is said that "knowledge is power." Purist that I am, I must contend that use of knowledge is power; otherwise it is just potential power.
Hanna has conflicted emotions in the case of a murdered drug dealer when he learns his Navy Seal comrades are involved.
Kidney cancer support group to meet
Treatment options for kidney cancer will be the topic of discussion at 1:30 p.m. Tuesday at Genesys Hurley Cancer institute, 302 Kensington in Flint.
Family offers support through rough waters of kidney cancer
My name is Leona Marie Santiago, and my Tlingit name is Kaaxkwei. I am from the Eagle Nation of the Wolf clan known as Kaagwaantaan from the Gooch Hit.
Renal Cancer: Protein Triggers A Snowball Effect
ETH researchers tracked down the phenomenon. Body cells divide incessantly. This is actually a "standard procedure", which in most cases proceeds without error.
Nederland Community Mourns Loss Of 27 Year-Old Teacher
An 8th Grade C.O. Wilson Middle School teacher died Thursday night after a two-year battle with kidney cancer.
Nederland teacher loses cancer battle
In less than three decades, Jodi Esquivel touched more lives than most can in a full lifetime.
Charity in memory of patients' champion
THE family of kidney cancer patient Andy Crabb plans to help other patients by setting up a charity in his memory.
Data Presented On Oncophage Cancer Vaccine In Recurrent Glioma At Sno 2009
Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco , has presented an update on a Phase 2 clinical trial of Oncophage for recurrent high grade glioma at the 2009 Joint Meeting of SNO and AANS/CNS Section on Tumors 2009 in New Orleans, LA.
Pair of Studies Offer Important Insight into Predicting Kidney Injury in Surgical Patients
Two studies presented at this week's Annual Meeting of the American Society of Anesthesiologists offer new information as to how physicians might better determine which surgical patients may be at risk for developing kidney injury after surgery.
BioMed News: Antigenics, Shire, King Pharma, Delcath Systems
On 6/1/09, Antigenics announced results of an interim analysis from the Company's ongoing global patient survival registry, which showed that patients with kidney cancer at intermediate risk of disease recurrence demonstrated an approximately 46% lower risk of death when treated with Oncophage cancer vaccine compared with observation .
Doug's Blog: Cancer free for three
Three years ago this week, I heard the three words that no one wants to hear "You have cancer." It hit me like a bomb.
GSK drug approved for kidney cancer treatment
PHILADELPHIA The Food and Drug Administration has approved a new drug from GlaxoSmithKline to treat advanced kidney cancer.
ASA: Studies Examine Urinary Biomarkers of Kidney Disease
The biomarker neutrophil gelatinase-associated lipocalin may best identify acute kidney injury in cardiac surgery patients with normal preoperative kidney function, and undetected kidney cancer may influence urine concentrations of another biomarker, kidney injury molecule-1 , according to research presented at the annual meeting of the American ...
EMEA informs Antigenics on a negative opinion for Oncophage MAA
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use , of the European Medicines Agency , has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application for Oncophage in early-stage, localized renal cell carcinoma .
FDA Approves GlaxoSmithKlinea s Votrient for Advanced Renal Cell Cancer
GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Votrient to treat patients with advanced renal cell carcinoma , a form of kidney cancer.
FDA approves new kidney cancer treatment
The U.S. Food and Drug Administration says it has approved a new kidney cancer medication -- the sixth such drug to be approved since 2005.
Tulane Doctor Kills Cancer Cells With Cold
A surgeon at New Orleans' Tulane University said he used extreme cold to freeze tumors and kill cancer cells inside of a patient.
Also on Topix